Tech Company Financing Transactions
Symic Biomedical Funding Round
Symic Biomedical, operating out of Emeryville, raised $11 million in funding from Cell Innovation Partners and private investors.
Transaction Overview
Company Name
Announced On
4/29/2019
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Undisclosed
Investors
Cell Innovation Partners (Lead Investor)
Proceeds Purpose
The financing will be utilized to advance Symic Bio's disease-modifying osteoarthritis drug, SB-061, into a global Phase 2b trial to be started in the latter half of 2019.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5980 Horton St. 600
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
Symic Biomedical is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ken Horne
Chief Financial Officer
Jocelyn Jackson
Chief Medical Officer
Nathan Bachtell
Chief Scientific Officer
Glenn Prestwich
Browse more venture capital transactions:
Prev: 4/29/2019: Lattice venture capital transaction
Next: 4/29/2019: FoodMaven venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. All VC database entries on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs